Literature DB >> 2587962

Immune mechanisms in the prevention of intra-abdominal abscess formation.

D L Kasper1, R F Finberg, J Crabb, A B Onderdonk.   

Abstract

Bacteroides fragilis is the most commonly isolated anaerobe from intraabdominal infections. In experimental models of intraabdominal sepsis, B. fragilis has been shown to be uniquely virulent. Some of these virulence traits are due to the capsular polysaccharide of this organism. Immunity to infection secondary to B. fragilis seems to involve both arms of the immune system. Humoral immunity (complement, antibody and PMNs) is critical to clearance of these bacteria from the blood stream. Cellular immune mechanisms predominate against intraabdominal abscess formation. Adoptive transfer experiments have shown that a CD8+, IJ+, non H2 restricted immune T cell or lysate from this T cell confers protection to immunocompetent, naive mice. An in vivo system has been developed to begin defining the mechanism of protection. B. fragilis placed inside a filter containment chamber within the peritoneum of immune mice are specifically killed over an 8-day period in the absence of white blood cells. This killing phenomenon was also observed inside filter chambers within mice receiving adoptively transferred immune T cells or lysates of these T cells. Furthermore, killing is specific to B. fragilis. These results support a T cell dependent mechanism for killing this bacteria and provide an interesting model for further exploration.

Entities:  

Mesh:

Year:  1989        PMID: 2587962

Source DB:  PubMed          Journal:  Scand J Infect Dis Suppl        ISSN: 0300-8878


  2 in total

1.  Structure and function relations with a T-cell-activating polysaccharide antigen using circular dichroism.

Authors:  Lori S C Kreisman; Julia H Friedman; Andreea Neaga; Brian A Cobb
Journal:  Glycobiology       Date:  2006-09-21       Impact factor: 4.313

2.  Structural characteristics of polysaccharides that induce protection against intra-abdominal abscess formation.

Authors:  A O Tzianabos; A B Onderdonk; D F Zaleznik; R S Smith; D L Kasper
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.